New Diagnostics Address Foodborne Illness Outbreaks
This article was originally published in The Gray Sheet
Executive Summary
FDA is showcasing new diagnostic technologies to address foodborne illness outbreaks, including a new test kit from a German manufacturer and a next-generation sequencing method developed by agency scientists.
You may also be interested in...
Experts: Molecular Tests Could Improve Antibiotic Clinical Trials
Greater acceptance of molecular tests that can identify rare and drug-resistant bacterial strains through their genetic material could transform antibiotics clinical trial design and lower the cost of developing new drugs, scientists said at a workshop on antibiotic drug resistance last week
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.